AbbVie Inc.
For the period ended May 8, 2026. Filed Mar 23, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
May 8, 2026 · Filed Mar 23, 2026
Contents
Cover page
Show cover page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934
| Filed by the Registrant ⌧ | |
|---|---|
| Filed by a Party other than the Registrant ◻ | |
| Check the appropriate box: | |
| ◻ | Preliminary Proxy Statement |
| ◻ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ⌧ | Definitive Proxy Statement |
| ◻ | Definitive Additional Materials |
| ◻ | Soliciting Material under §240.14a-12 |
| | |
|---|---|
| AbbVie Inc. | |
| (Name of Registrant as Specified In Its Charter) | |
| (Name of Person(s) Filing Proxy Statement, if other than the Registrant) | |
| Payment of Filing Fee (Check the appropriate box): | |
| ⌧ | No fee required. |
| ◻ | Fee paid previously with preliminary materials. |
| ◻ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11. |
Notice of 2026Annual Meetingof Stockholders
To the stockholders of our company:
You are cordially invited to attend the 2026 Annual Meeting of Stockholders to be held on May 8, 2026, where we will be voting on the below matters. You will be able to attend the Annual Meeting, vote, and submit questions via live webcast by visitingwww.virtualshareholdermeeting.com/ABBV2026.
Items of business
| ● | To elect four directors to hold office until the 2029 Annual Meeting or until their successors are elected. |
| ● | To ratify the appointment of Ernst & Young LLP as AbbVie’s independent registered public accounting firm for 2026. |
| ● | To vote on an advisory basis on the approval of executive compensation. |
| ● | To vote on a management proposal to eliminate supermajority voting. |
| ● | To consider any other matters that may properly come before the meeting, including one stockholder proposal, if presented during the meeting. |
| | |||
|---|---|---|---|
| Your vote is important.Please vote promptly using one of the methods mentioned below:InternetVisit www.proxyvote.com to vote online.MailSign and return your proxy card in the enclosed envelope if you received a printed version of the proxy card.TelephoneCall toll-free 1-800-690-6903 in the U.S. and Canada.At the virtual meetingTo be admitted to the virtual meeting, you must enter the control number found on your proxy card, voting instructions form, or notice you received. | The Annual Meeting of Stockholders of AbbVie Inc. (the “Annual Meeting”) will be held on Friday, May 8, 2026 at 9:00 a.m. CT. This year’s Annual Meeting will be a virtual meeting of stockholders. | ||
| DATE AND TIME:Friday, May 8, 20269:00 a.m. CT | WHERE:Via live webcast online atwww.virtualshareholdermeeting.com/ABBV2026. | ADMISSION:Stockholders of record at the close of business on March 9, 2026 are entitled to notice of and to vote at the annual meeting. | |
| Thank you for your continued support of and interest in the company. | |||
| | By Order of the Board of Directors, | ||
| | | ||
| | Perry C. Siatis | ||
| SecretaryMarch 23, 2026 | |||
TABLE OF CONTENTS
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.